Related Experiment Video
Updated: Jun 27, 2025

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Intrahepatic Cholestasis of Pregnancy during COVID-19 Pandemic
Paulina Malarkiewicz1, Urszula Nowacka2, Aleksandra Januszaniec2
1Department of Obstetrics and Gynecology, School of Medicine, Collegium Medicum of the University of Warmia and Mazury, al. Warszawska 30, 10-082 Olsztyn, Poland.
Insights
The incidence of intrahepatic cholestasis of pregnancy (ICP) decreased during the COVID-19 pandemic, mainly due to fewer mild cases. Moderate and severe ICP rates remained stable, suggesting potential detection or access issues during the pandemic.
Area of Science:
- Maternal-Fetal Medicine
- Hepatology
- Infectious Diseases
Background:
- Intrahepatic cholestasis of pregnancy (ICP) is a common pregnancy complication impacting fetal health.
- COVID-19 infection can cause liver injury, raising questions about its interaction with ICP.
- This study investigates the potential interplay between ICP and the COVID-19 pandemic.
Purpose of the Study:
- To compare the incidence and severity of ICP before and during the COVID-19 pandemic.
- To analyze how the pandemic might have affected ICP diagnosis and outcomes.
Main Methods:
- Retrospective cohort study of 7799 deliveries across two hospitals.
- Comparison of ICP data from January 2018-February 2020 (pre-COVID-19) and March 2020-March 2022 (COVID-19 period).
- ICP diagnosed via ICD-10 code, defined by total bile acids (BA) ≥ 10 μmol/L; statistical analyses included Chi-square and Mann-Whitney U tests, and regression analysis.
Main Results:
- Overall ICP incidence was lower during the pandemic (2.4%) compared to pre-pandemic (3.6%), p=0.01.
- Mild ICP incidence decreased significantly (3% pre- vs. 2% during pandemic, p<0.05).
- Moderate and severe ICP incidence, along with neonatal outcomes, showed no significant changes.
Conclusions:
- The COVID-19 pandemic was associated with a lower overall incidence of ICP, driven by a reduction in mild cases.
- The unchanged incidence of moderate to severe ICP suggests these forms were less affected by pandemic circumstances.
- Potential factors for reduced mild ICP include altered medical access or diagnostic challenges during the pandemic.
Abstract:
Background and Objectives: Intrahepatic cholestasis of pregnancy (ICP) stands as one of the most prevalent concerns in maternal-fetal medicine, presenting a significant risk to fetal health and often associated with liver dysfunction. Concurrently, the coronavirus-19 (COVID-19) infection can lead to hepatic cell injury through both direct and indirect pathways. Hypothetically, these two conditions may coincide, influencing each other. This study aimed to comparatively assess the incidence and severity of ICP before and during the COVID-19 pandemic. Methods: A retrospective cohort study was conducted, comparing the incidence and severity of ICP between January 2018 and February 2020 (pre-COVID-19 period) and March 2020 to March 2022 (COVID-19 period) across two hospitals, encompassing 7799 deliveries. The diagnosis of ICP was established using the ICD-10 code and defined as total bile acids (BA) levels ≥ 10 μmol/L. Statistical analysis included descriptive statistics, Chi-square and Mann-Whitney U tests, as well as multiple or logistic regression analysis. Results: A total of 226 cases of ICP were identified. The incidence of mild cholestasis (BA < 40 μmol/L) was lower during the pandemic compared to before (3% before versus 2%, p < 0.05), while the incidence of moderate and severe ICP remained unchanged (0.6% before vs. 0.4%, p = 0.2). Overall, the total incidence of ICP was lower during the pandemic (3.6% before versus 2.4%, p = 0.01). No significant differences were observed in severity (as defined by BA and liver function test levels), rates of caesarean section, or neonatal birth weights. Conclusions: During the COVID-19 pandemic, the total incidence of ICP appeared to be lower. However, this reduction was primarily observed in cases of mild ICP, potentially indicating challenges in detection or reduced access to medical services during this period. The incidence of moderate and severe ICP remained unchanged, suggesting that these forms of the condition were unaffected by the pandemic's circumstances.
More Related Videos
11:08The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024